International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 322-329 doi: 10.5281/zenodo.16730489
Original Article
Triglyceride-Glucose Index And Hypertension Risk: A Cross-Sectional Study Comparing Diagnostic Criteria
 ,
 ,
Published
Aug. 2, 2025
Abstract

Background: The triglyceride-glucose (TyG) index has emerged as a simple surrogate marker for insulin resistance and cardiovascular risk. However, its association with hypertension remains understudied in clinical populations using multiple diagnostic definitions.

Objective: To assess the association between TyG index and hypertension risk in adults and compare how different hypertension diagnostic criteria affect this relationship.

Methods: A cross-sectional study was conducted among 450 adults attending SLN Medical College and Hospital, Koraput, over a 4-month period. Fasting triglyceride and glucose levels were used to compute the TyG index. Blood pressure was measured using standardized procedures. Hypertension was defined using both ACC/AHA (≥130/80 mmHg) and JNC-8 (≥140/90 mmHg) guidelines. Participants were categorized into TyG quartiles. Logistic and linear regression models assessed associations with hypertension and blood pressure, adjusting for age, body mass index (BMI), and smoking status.

Results: Hypertension prevalence (ACC/AHA) increased from 9.7% in the lowest TyG quartile to 26.8% in the highest (p = .0368). Logistic regression showed TyG Index significantly predicted hypertension (OR = 2.47; 95% CI: 0.24–1.57; p = .0075). In multivariable linear regression, TyG was independently associated with systolic blood pressure (β = 3.16; p = .0060), but not with diastolic pressure. Model fit was strong (Nagelkerke R² = 1.000).

Conclusion: Higher TyG Index levels are significantly associated with increased risk of hypertension and elevated systolic blood pressure. The TyG Index may serve as a practical, non-invasive biomarker for early hypertension screening and risk stratification.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
304 Views
274 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved